An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves Novo Nordisk’s Awiqli® On March 26, Novo Nordisk announced that the US Food and Drug Administration (FDA) approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin, indicated as an adjunct to diet and...
Zeb I. Saeed, MD, a member of the steering committee for the Endocrine Society’s Early Career Special Interest Group (SIG), shares with clinicians three patient-centric principles to treating overweight and obesity. As endocrinologists, we enter clinical practice having been well trained in the physiology and pharmacological management of obesity, what the BMI cutoffs are, and...
INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA). This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to...
Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching...
A recent JCEM paper has indicted obesity as the possible cause of yet another disease – vascular-related dementia. Targeting obesity and hypertension with medications and other weight-loss interventions could prevent developing dementia. In a 2007 paper published in Obesity Reviews, the late Sir David Haslam wrote that the origins of obesity can be traced back...
The Endocrine Society has selected five recipients for its Early Investigator Awards. The Early Investigators Awards were established to help develop early career investigators and recognize their accomplishments in endocrine-related research. Recipients will receive a $1,500 monetary award, complimentary registration and the opportunity to present at ENDO 2026, one year of free membership to the Society, and public recognition of research accomplishments in various Society platforms. ...
Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may influence how children’s bones develop during adolescence, according to new research published in the Journal of the Endocrine Society. PFAS are synthetic chemicals found in water, food and everyday products. These “forever chemicals,” many of which persist in the environment and in the human body, may interfere with normal development, including bone growth. “Adolescence is a key period for...
Endocrine News speaks with Rebecca Reynolds, MD, PhD, the Endocrine Society’s 2026 International Excellence in Endocrinology Laureate Award, about why so much of women’s health begins in pregnancy as well as the many unanswered questions about fetal growth. The earliest stages of life can shape health for decades, and Rebecca Reynolds, MD, PhD, has dedicated...
Endocrine News speaks with Rebecca Reynolds, MD, PhD, the Endocrine Society’s 2026 International Excellence in Endocrinology Laureate Award, about why so much of women’s health begins in pregnancy as well as the many unanswered questions about fetal growth. The earliest stages of life can shape health for decades, and Rebecca Reynolds, MD, PhD, has dedicated...
